Virtuleap launches Cogniclear VR for early cognitive screening
Home News Virtuleap launches Cogniclear VR for early cognitive screening

Virtuleap launches Cogniclear VR for early cognitive screening

NOVEMBER 18, 2024 BHH Members Initiatives

Cogniclear VR, an innovative new virtual reality-based cognitive assessment tool developed by BHH member Virtuleap, is set to redefine how cognitive impairments are detected and monitored. Unlike traditional pen-and-paper tests, Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.

Current screening methods like the MMSE or MoCA, though reliable, often miss the earliest signs of cognitive decline. Cogniclear VR fills this gap by offering an advanced, ecologically valid approach that reflects real-world tasks, enabling earlier and more accurate detection of cognitive impairments. This cutting-edge system equips healthcare providers with detailed reports that eliminate subjective interpretation, ensuring clearer insights into a patient’s cognitive health. Cogniclear VR features 14 exercises across eight cognitive domains, including memory, attention, problem-solving, and motor control, all designed to simulate daily challenges. The result is a more relevant and impactful assessment of cognitive abilities.

"Cogniclear VR was incubated as part of Roche's 'Building Together Tomorrow' dementia program, which Virtuleap joined in spring 2022. Since then, it has undergone two years of rigorous development, in close collaboration with our hospital partners, to reach this pivotal launch," said Amir Bozorgzadeh, CEO at Virtuleap. "Cogniclear VR is positioned to be a key tool in early cognitive diagnosis and ongoing care, helping individuals maintain independence and quality of life."

Designed for accessibility, Cogniclear VR ensures that users of all technological backgrounds can engage easily with the platform, thanks to its intuitive onboarding process. As a VR-based tool, Cogniclear VR creates an ecologically valid, multisensory environment that immerses users in realistic scenarios, engaging the full body and capturing observational data that traditional assessments miss. Whether used in clinics or remotely, this advanced screening approach empowers clinicians to monitor cognitive changes over time, enabling earlier, more informed intervention when needed.

"When I began developing clinical VR applications in the mid-90s, the first area where I recognized its immense potential was in neurocognitive assessment and rehabilitation. Since then, research, science, and development in this field have steadily progressed, addressing the needs of individuals with central nervous system damage or dysfunction. Nearly 30 years later, Virtuleap embodies what makes sense in this area." said Albert "Skip" Rizzo, PhD, Director of Medical Virtual Reality at USC’s Institute for Creative Technologies.

He continued: "They have developed high-fidelity VR simulations for cognitive testing and training that are scientifically informed, reasonably priced, and engaging for users. The days of relying solely on neuropsychological tools that have seen little advancement since the mid-20th century are over. Virtuleap offers cognitive training and evaluation activities that immerse users in rehabilitative exercises, driving cognitive activation while a backend system quantifies performance and adjusts challenge levels. These tools hold great potential for making a positive impact in people's lives!"

Cogniclear VR also complements Enhance VR, Virtuleap's cognitive training library, which includes 15 gamified exercises based on validated neuropsychological tools. These exercises target seven key cognitive abilities and have been proven effective in various studies, including pilot research on young adults with ADHD and individuals with intellectual and developmental disabilities (IDD). Together, Cogniclear VR and Enhance VR offer a comprehensive approach to cognitive health, from assessment to continuous training.

Launching simultaneously with Cogniclear VR, Virtuleap has also unveiled a complete rebranding and a new website. The refreshed site now includes a comprehensive knowledge center and a SaaS platform designed to support healthcare professionals, researchers, and users in exploring cognitive health solutions and tracking progress with ease. This initiative aligns with Virtuleap's commitment to empowering cognitive health management through accessible, data-driven tools.

Discover more HERE

December 03, 2024 BHH Members Initiatives
Barça Innovation Hub joins Genomcore shareholders
Barça Innovation Hub (BIHUB) co-invests alongside US-based investment firm QVIDTVM to support Genomcore’s expansion in biomedical data management and sports innovation.
Read more
November 25, 2024 BHH Members Initiatives
VB Devices expands its international presence with VARIXIO to over 30 countries
VB Devices will have expanded its international presence with VARIXIO to over 30 countries by the end of 2024. 
Read more
November 18, 2024 BHH Members Initiatives
Virtuleap launches Cogniclear VR for early cognitive screening
Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
Read more
November 13, 2024 BHH Members Initiatives
Participate in the lottery to mitigate pharmaceutical poverty
Once again Banco Farmacéutico sells lottery tickets in order to mitigate pharmaceutical poverty.
Read more
November 11, 2024 BHH Members Initiatives
Spanish HCB Hospitales introduces online care with Dutch technology
Spanish HCB Hospitales (Hospital Clínica Benidorm) becomes the first hospital in Spain to use screen care from Webcamconsult.
Read more
November 07, 2024 BHH Members Initiatives
Keito Group to participate in the global healthcare technology event Medica, in Düsseldorf
Keito Group is excited to announce its participation in the upcoming Medica 2024 trade fair, held from 11 to 14 November 2024 in Düsseldorf, Germany.
Read more
November 05, 2024 BHH Members Initiatives
Low Code and AI: Revolutionizing medicine with Onizea
Low Code platforms are empowering healthcare professionals to create custom applications—fast.
Read more
October 29, 2024 BHH Members Initiatives
FemmeUp and SANNO collaborate to raise awareness about women’s health, focusing on menopause and gut health
This collaboration aims to provide comprehensive solutions by combining FemmeUp's expertise in natural supplements with SANNO's patient management software for clinics and research.
Read more
October 29, 2024 BHH Members Initiatives
INBRAIN Neuroelectronics raises $50M Series B to advance graphene-based brain-computer interface technology
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath Bioventures.
Read more
October 28, 2024 BHH Members Initiatives
Reig Jofre enters the digital health market with remote joint physiotherapy services based on AI
The pharmaceutical company has partnered with Catalan startup DyCare to offer digital solutions that allow patients to perform exercises at home, expanding its presence in both the Spanish and French markets.
Read more